Category:
Sera and Vaccines
CAS NO:
910463-68-2
Standard:
In-house Standards,
Indications:
Mechanism of Action: Semaglutide is a GLP-1 analog that enhances glucose-dependent insulin secretion, decreases glucagon secretion, and slows gastric emptying. This leads to reduced blood glucose levels.